Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Hospices Civils de Lyon |
---|---|
Information provided by: | Hospices Civils de Lyon |
ClinicalTrials.gov Identifier: | NCT00146926 |
Propofol is a popular intravenous drug to induce anesthesia but it causes local pain with an incidence between 40 and 90%. Three different strategies to prevent propofol induced pain will be studied compared with placebo. Pain will be scored with a four-point scale.
Condition | Intervention | Phase |
---|---|---|
Induction of Total Intravenous General Anesthesia |
Drug: kétamine 20mg Drug: ephedrine 3mg Drug: lidocaine 40mg |
Phase III |
Study Type: | Interventional |
Study Design: | Randomized, Double-Blind, Placebo Control, Parallel Assignment |
Official Title: | Comparison of Three Different Strategies to Prevent Propofol Induced Pain During Infusion |
Estimated Enrollment: | 200 |
Study Start Date: | September 2005 |
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Healthy adults (ASA 1-2) for scheduled surgery under general anesthesia with propofol
Exclusion Criteria:
Study ID Numbers: | 2004.367 |
Study First Received: | September 5, 2005 |
Last Updated: | April 26, 2007 |
ClinicalTrials.gov Identifier: | NCT00146926 |
Health Authority: | France: Afssaps - French Health Products Safety Agency |
Propofol pain general anesthesia prevention |
Pseudoephedrine Ketamine Lidocaine |
Ephedrine Pain Propofol |
Anesthetics, Intravenous Anesthetics, General Therapeutic Uses Hypnotics and Sedatives Physiological Effects of Drugs |
Central Nervous System Depressants Anesthetics Central Nervous System Agents Pharmacologic Actions |